Catalent Pharma Solutions

April 2, 2019

Sponsored Content

Catalent Biologics’ Bloomington, Indiana facility provides sterile formulation and extensive biomanufacturing and drug product fill/finish capacity across a number of biological drug product formats.

Catalent Biologics’ Bloomington, Indiana facility provides sterile formulation and extensive biomanufacturing and drug product fill/finish capacity across a number of biological drug product formats.

The site recently achieved regulatory approval for a 20th commercial product and investment of over $100 million has been announced to expand manufacturing and packaging capabilities, increasing flexibility and capacity.

Catalent
CPhI North America Booth #1206